Novalung GmbH continues expansion into Scandinavia
The world’s first pumpless lung assist device, the iLA Membrane Ventilator®, now exclusively available in Sweden and Norway through Vingmed Group.
(firmenpresse) - The world’s first pumpless lung assist device, the iLA Membrane Ventilator®, now exclusively available in Sweden and Norway through Vingmed Group.
Novalung GmbH, the German manufacturer of the world’s leading therapeutic system for extrapulmonary lung support, has signed exclusive agreements with Vingmed Svenska AB and Vingmed AS for distribution of the iLA Membrane Ventilator® in Sweden and Norway, respectively.
Dr. Torsten Rinne, Medical Director of Novalung GmbH, noted: “We have seen the application of the iLA Membrane Ventilator extend increasingly to the support of patients with acute exacerbations of chronic lung disease (COPD). Thus, it is exciting to see how Vingmed has embraced the concept of helping these patients by combining extrapulmonary CO2 removal with non-invasive ventilation as a way of limiting the negative effects that mechanical ventilation can have on their already damaged lungs.”
Of 185 patients added to the company’s iLA Patient Registry in 2009, almost 60% were patients with an acute worsening of a chronic disease (so called exacerbations). The Registry currently includes roughly 10% of the nearly 5,000 patients treated worldwide with the iLA Membrane Ventilator to date. Rinne comments: “Now that we have expanded the iLA Patient Registry to enable all of our customers to actively submit their clinical data, we look forward to a further significant increase in the data pool of COPD patients successfully treated with the iLA Membrane Ventilator. We hope that Vingmed’s customers will be significant contributors to the Registry.”
The Vingmed Group companies were chosen by Novalung due to their decades of experience with innovative medical procedures and their reputation for excellence in customer support. “The iLA Membrane Ventilator is a perfect addition to our current range of products” said Petter Solum of Vingmed AS.
The therapeutic aspects of using the iLA Membrane Ventilator and its relation to other extracorporeal therapies such as ECMO were presented to the participants of the annual meeting of the society of Swedish perfusionists (Swesect) in January 2010 in Visingsö, Sweden.
Unternehmensinformation / Kurzprofil:
Datum: 31.03.2010 - 11:34 Uhr
Sprache: Deutsch
News-ID 18408
Anzahl Zeichen: 0
contact information:
Kategorie:
Healthcare & Medical
Typ of Press Release: Kooperation
type of sending: Veröffentlichung
Diese Pressemitteilung wurde bisher 843 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Novalung GmbH continues expansion into Scandinavia"
steht unter der journalistisch-redaktionellen Verantwortung von
Novalung GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
